Literature DB >> 17907295

Effects of H pylori infection on gap-junctional intercellular communication and proliferation of gastric epithelial cells in vitro.

Ran Tao1, Miao-Feng Hu, Jin-Tu Lou, Yong-Liang Lei.   

Abstract

AIM: To explore the effects of H pylori infection on gap-junctional intercellular communication (GJIC) and proliferation of gastric epithelial cells in vitro.
METHODS: A human gastric epithelial cell line (SGC-7901) cultured on coverslips was exposed overnight to intact H pylori (CagA(+) or CagA(-) strains) and sonicated extracts, respectively. GJIC between the cells was detected by fluorescence redistribution after photobleaching (FRAP) technique. Proliferation of SGC cells was determined by methylthiazolyl tetrazolium (MTT) assay.
RESULTS: When compared with control in which cells were cultured with simple medium alone, both CagA(+) and CagA(-) H pylori isolates could inhibit GJIC (CagA(+): F = 57.98, P < 0.01; CagA(-): F = 29.59, P < 0.01) and proliferation (CagA(+): F = 42.65, P < 0.01; CagA(-): F = 58.14, P < 0.01) of SGC-7901 cells. Compared with CagA(-) strains, CagA(+) H pylori more significantly down-regulated GJIC of gastric cells (intact H pylori: t = 13.86, P < 0.01; sonicated extracts: t = 11.87, P < 0.01) and inhibited proliferation gastric cells to a lesser extent in vitro (intact H pylori: t = 3.06, P < 0.05; sonicated extracts: t = 3.94, P < 0.01).
CONCLUSION: Compared with CagA(-) H pylori strains, CagA(+) strains down-regulate GJIC of gastric epithelial cells more significantly and inhibit proliferation of gastric cells to a lesser extent in vitro. H pylori, especially CagA(+) strains, may play an important role in gastric carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17907295      PMCID: PMC4171286          DOI: 10.3748/wjg.v13.i41.5497

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

1.  Effect of Helicobacter pylori infection on gastric epithelial cell proliferation.

Authors:  Hong Gao; Ji-Yao Wang; Xi-Zhong Shen; Jian-Jun Liu
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

2.  Preventive effect of germanium dioxide on the inhibition of gap junctional intercellular communication by TPA.

Authors:  K S Kang; J W Yun; B Yoon; Y K Lim; Y S Lee
Journal:  Cancer Lett       Date:  2001-05-26       Impact factor: 8.679

Review 3.  Role of disrupted gap junctional intercellular communication in detection and characterization of carcinogens.

Authors:  H Yamasaki
Journal:  Mutat Res       Date:  1996-09       Impact factor: 2.433

4.  Effects of Helicobacter pylori on proliferation of gastric epithelial cells in vitro.

Authors:  D T Smoot; Z Wynn; T B Elliott; C R Allen; G Mekasha; T Naab; H Ashktorab
Journal:  Am J Gastroenterol       Date:  1999-06       Impact factor: 10.864

Review 5.  Role of connexin (gap junction) genes in cell growth control and carcinogenesis.

Authors:  H Yamasaki; V Krutovskikh; M Mesnil; T Tanaka; M L Zaidan-Dagli; Y Omori
Journal:  C R Acad Sci III       Date:  1999 Feb-Mar

6.  Reduction of gap junction protein connexin 32 in rat atrophic gastric mucosa as an early event in carcinogenesis.

Authors:  A Nagahara; S Watanabe; H Miwa; K Endo; M Hirose; N Sato
Journal:  J Gastroenterol       Date:  1996-08       Impact factor: 7.527

7.  Immunohistochemistry of gap junctions in normal and diseased gastric mucosa of humans.

Authors:  Y Uchida; K Matsuda; K Sasahara; H Kawabata; M Nishioka
Journal:  Gastroenterology       Date:  1995-11       Impact factor: 22.682

8.  Gastric epithelial cell proliferation and cagA status in Helicobacter pylori gastritis at different gastric sites.

Authors:  Mônica M D A Cabral; Celso A Oliveira; Cláudia M C Mendes; Juliana Guerra; Dulciene M M Queiroz; Gifone A Rocha; Andreia M C Rocha; Ana M M F Nogueira
Journal:  Scand J Gastroenterol       Date:  2007-05       Impact factor: 2.423

9.  Development of gastric adenocarcinoma in Mongolian gerbils after long-term infection with Helicobacter pylori.

Authors:  Qing Zheng; Xiao Yu Chen; Yao Shi; Shu Dong Xiao
Journal:  J Gastroenterol Hepatol       Date:  2004-10       Impact factor: 4.029

10.  Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach.

Authors:  M J Blaser; G I Perez-Perez; H Kleanthous; T L Cover; R M Peek; P H Chyou; G N Stemmermann; A Nomura
Journal:  Cancer Res       Date:  1995-05-15       Impact factor: 12.701

View more
  6 in total

Review 1.  Helicobacter pylori in First Nations and recent immigrant populations in Canada.

Authors:  Nicola Jones; Naoki Chiba; Carlo Fallone; Alan Thompson; Richard Hunt; Kevan Jacobson; Karen Goodman
Journal:  Can J Gastroenterol       Date:  2012-02       Impact factor: 3.522

Review 2.  Modulation of connexin signaling by bacterial pathogens and their toxins.

Authors:  Liesbeth Ceelen; Freddy Haesebrouck; Tamara Vanhaecke; Vera Rogiers; Mathieu Vinken
Journal:  Cell Mol Life Sci       Date:  2011-06-09       Impact factor: 9.261

3.  Variations in the multimerization region of the Helicobacter pylori cytotoxin CagA affect virulence.

Authors:  Daiva Ahire; Tricia Alston; Robert Raffaniello
Journal:  Oncol Lett       Date:  2017-01-02       Impact factor: 2.967

Review 4.  Connexin and pannexin signaling in gastrointestinal and liver disease.

Authors:  Michaël Maes; Sara Crespo Yanguas; Joost Willebrords; Bruno Cogliati; Mathieu Vinken
Journal:  Transl Res       Date:  2015-05-16       Impact factor: 7.012

Review 5.  Connexins and their channels in inflammation.

Authors:  Joost Willebrords; Sara Crespo Yanguas; Michaël Maes; Elke Decrock; Nan Wang; Luc Leybaert; Brenda R Kwak; Colin R Green; Bruno Cogliati; Mathieu Vinken
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-07-07       Impact factor: 8.250

6.  "Targeted disruption of the epithelial-barrier by Helicobacter pylori".

Authors:  Lydia E Wroblewski; Richard M Peek
Journal:  Cell Commun Signal       Date:  2011-11-01       Impact factor: 5.712

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.